CD36 and breast cancer: On the contrary, CD36+ fibroblast cause inhibition of breast cancer cell proliferation by secreting proteins like SLIT3, PENK and FBLN1 (Jabbari et al., 2021; Jabbari et al., 2022), indicating that CD36+ fibroblasts may play an anti-tumoral role.